ArticleHarm reduction journal2025
Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial survey.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sexually transmitted and bloodborne infections testing among people who use substances: findings from the 2023 British Columbia Harm Reduction Client Survey.BMC infectious diseases · 2026Article
- Exploring the early impacts of drug decriminalization on harm reduction and opioid agonist treatment service operations and delivery in British Columbia: insights from key informant interviews.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundIn January 2023, British Columbia (BC), Canada, piloted a three-year decriminalization policy to address the escalating overdose crisis. The policy seeks to reduce stigma and the fear of criminal prosecution, and foster a safer and more supportive environment, encouraging greater utilization of treatment and harm reduction (HR) services among people who use drugs. There are limited data on the operational characteristics of HR sites in BC, which are essential for monitoring how decriminalization may influence service operations and utilization. This study aimed to characterize HR site operations in BC and assess any operational changes following decriminalization.
methodsA cross-sectional, online self-report survey was distributed to HR sites across BC between March and April 2024. The survey was completed by a site representative, and survey questions focused on client demographics and drug use patterns, service uptake and capacity, resource and staffing demands, police activity near sites, and the availability of HR services. Changes pre-and post-decriminalization were analyzed descriptively to identify trends.
resultsA total of 33 HR sites completed the survey. Almost a third (30%) of sites reported an increase in client's post-decriminalization, and 18% indicated plans to expand or modify services to meet the increasing demand. However, challenges related to staffing and resources were highlighted, with 45% of sites reporting increased staffing demands post-decriminalization, and 33% noting changes to resource needs, most of which increased. Five sites reported an increase in annual operating budgets. Nearly half (43%) of sites that experienced police activity around their site reported increased police activity post-decriminalization. Moreover, approximately one-fifth (21%) of sites received formal decriminalization training.
conclusionsHR sites have experienced an increase in client engagement post-decriminalization, reporting challenges related to site capacity and funding, and emphasizing the need for additional investments to support and expand HR services. Consideration should be given to needs-based planning and providing decriminalization training to HR staff. Moreover, steps are necessary to address the continued police presence near sites, which may hinder service uptake and perpetuate stigma. Addressing these gaps is critical for improving health system engagement for people who use drugs and achieving the goals of decriminalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.